Orlistat (Xenical) in the Treatment of Overweight Patients With Nonalcoholic Steatohepatitis (NASH).
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Orlistat (Primary)
- Indications Obesity
- Focus Therapeutic Use
- 23 Nov 2007 The expected completion date for this trial is now 1 Dec 2006.
- 19 Nov 2007 Status changed from in progress to completed.
- 19 Oct 2006 Status change